학술논문

Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy
Document Type
article
Source
Cell Cycle. 13(24)
Subject
Cancer
Animals
Antineoplastic Agents
Cell Line
Tumor
Humans
Interphase
Mice
Mice
Nude
Salmonella typhimurium
Stomach Neoplasms
Time-Lapse Imaging
Xenograft Model Antitumor Assays
cell cycle
chemotherapy
decoy
FUCCI
GFP
RFP
imaging
S
typhimurium A1-R
tumor-targeting bacteria
fluorescence ubiquitination-based cell cycle indicator
typhimurium
GFP
RFP
imaging
S. typhimurium A1-R
fluorescence ubiquitination-based cell cycle indicator
S. typhimurium
Biochemistry and Cell Biology
Developmental Biology
Language
Abstract
Quiescent cancer cells are resistant to cytotoxic agents which target only proliferating cancer cells. Time-lapse imaging demonstrated that tumor-targeting Salmonella typhimurium A1-R (A1-R) decoyed cancer cells in monolayer culture and in tumor spheres to cycle from G0/G1 to S/G2/M, as demonstrated by fluorescence ubiquitination-based cell cycle indicator (FUCCI) imaging. A1-R infection of FUCCI-expressing subcutaneous tumors growing in nude mice also decoyed quiescent cancer cells, which were the majority of the cells in the tumors, to cycle from G0/G1 to S/G2/M, thereby making them sensitive to cytotoxic agents. The combination of A1-R and cisplatinum or paclitaxel reduced tumor size compared with A1-R monotherapy or cisplatinum or paclitaxel alone. The results of this study demonstrate that A1-R can decoy quiescent cancer cells to cycle to S/G2/M and sensitize them to cytotoxic chemotherapy. These results suggest a new paradigm of bacterial-decoy chemotherapy of cancer.